Stella Wilson

Yeni makale yazdı

4 yıllar önce - çevirmek

Covid-19 Updates | Targeted Protein Degradation Enabling Technologies Market is anticipated to be worth over USD 3.3 billion by 2030 | #targeted Protein Degradation

Covid-19 Updates | Targeted Protein Degradation Enabling Technologies Market is anticipated to be worth over USD 3.3 bil

Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare

Yeni makale yazdı

4 yıllar önce - çevirmek

Covid-19 Updates | Cell Therapy Manufacturing Market is estimated to reach close to USD 11 Billion by 2030 | #cell Therapy Manufacturing

Covid-19 Updates | Cell Therapy Manufacturing Market is estimated to reach close to USD 11 Billion by 2030

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers

Yeni makale yazdı

4 yıllar önce - çevirmek

Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 13.9 billion in 2030 | #biopharmaceutical Contract Manufacturing

Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 13.9 billion in 2030

Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs

Yeni makale yazdı

Covid-19 Updates | Antibody Contract Manufacturing Market is estimated to be worth USD 17 billion in 2030 | #antibody Contract Manufacturing # Antibody Contract Manufacturing Market # Antibody Contract Manufacturing Market Research Report # Antibody Contract Manufacturing Market size # Antibody Contract Manufacturing Market growth # Antibody Contract Manufacturing Market revenue # Antibody Contract Manufacturing Market Analysis # Antibody Contract Manufacturing Industry Forecast

Covid-19 Updates | Antibody Contract Manufacturing Market is estimated to be worth USD 17 billion in 2030

The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well

Yeni makale yazdı

4 yıllar önce - çevirmek

Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030 | Roots Analysis | #target Protein Degradation # Target Protein Degradation Market # Target Protein Degradation Market Research Report # Target Protein Degradation Market size # Target Protein Degradation Market growth # Target Protein Degradation Market revenue # Target Protein Degradation Market Analysis # Target Protein Degradation Industry Forecast

Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030 | Roots Analysis

More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts